118 related articles for article (PubMed ID: 9209318)
1. Lifetime treatment of mice with azidothymidine (AZT) produces myelodysplasia.
Inoue T; Cronkite EP; Hirabayashi Y; Bullis JE; Mitsui H; Umemura T
Leukemia; 1997 Apr; 11 Suppl 3():123-7. PubMed ID: 9209318
[TBL] [Abstract][Full Text] [Related]
2. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
4. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice.
Prakash O; Teng S; Ali M; Zhu X; Coleman R; Dabdoub RA; Chambers R; Aw TY; Flores SC; Joshi BH
Arch Biochem Biophys; 1997 Jul; 343(2):173-80. PubMed ID: 9224727
[TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
6. In vivo toxicity of 3'-azido-3'-deoxythymidine (AZT) on CBA/Ca mice.
Cronkite EP; Bullis J
Int J Cell Cloning; 1990 Sep; 8(5):332-45. PubMed ID: 2230284
[TBL] [Abstract][Full Text] [Related]
7. Hemotoxic effects on mice of combined administration of azidothymidine and acyclovir.
Bogliolo G; Lerza R; Mencoboni M; Flego G; Gasparini L; Pannacciulli I
Exp Hematol; 1991 Sep; 19(8):838-41. PubMed ID: 1868898
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
9. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
10. 3'-Azido-3'-deoxythymidine ameliorates the thrombocytopenia observed in a murine model of AIDS.
Chow FP; Sutton PA; Hamburger AW
Exp Hematol; 1990 Oct; 18(9):1038-41. PubMed ID: 2168839
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
13. [Histopathology and morphometry of hematopoiesis in bone marrow of AIDS patients in comparison with patients with myelodysplastic syndrome].
Kaloutsi V; Maschek H; Kohlmeyer U; Nafe R; Choritz H; Amor A; Georgii A
Verh Dtsch Ges Pathol; 1991; 75():131-5. PubMed ID: 1724815
[TBL] [Abstract][Full Text] [Related]
14. Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice.
Rao GN; Lindamood C; Heath JE; Farnell DR; Giles HD
Toxicol Sci; 1998 Sep; 45(1):113-27. PubMed ID: 9848118
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
Chow FP; Hamburger AW
Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
[TBL] [Abstract][Full Text] [Related]
16. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
17. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
Richman DD; Fischl MA; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Hirsch MS
N Engl J Med; 1987 Jul; 317(4):192-7. PubMed ID: 3299090
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine toxicity to murine bone marrow may be affected by the exact frequency of drug administration.
Agur Z; Arnon R; Sandak B; Schechter B
Exp Hematol; 1991 Jun; 19(5):364-8. PubMed ID: 2026186
[TBL] [Abstract][Full Text] [Related]
19. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
Hamburger AW; Zsebo K; Chow FP
Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
